Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
105.63
-0.75 (-0.71%)
At close: May 13, 2025, 4:00 PM
106.35
+0.72 (0.68%)
Pre-market: May 14, 2025, 4:05 AM EDT

Ligand Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-132.62-4.0352.15-33.3657.14-2.99
Upgrade
Depreciation & Amortization
34.7835.2436.5238.3250.9527.97
Upgrade
Other Amortization
2.762.611.986.2621.5324.69
Upgrade
Loss (Gain) From Sale of Assets
---2.12---17.11
Upgrade
Asset Writedown & Restructuring Costs
30.5730.570.92---
Upgrade
Loss (Gain) From Sale of Investments
79.01-43.44-47.68-28.524.1118.41
Upgrade
Loss (Gain) on Equity Investments
10.4712.821.83---
Upgrade
Stock-Based Compensation
41.5941.0925.7450.8838.7830.73
Upgrade
Other Operating Activities
-19.642.8314.6416.54-36.71-15.43
Upgrade
Change in Accounts Receivable
-10.5-6.46-2.655.32-28.62-26.06
Upgrade
Change in Inventory
6.499.62-10.8712.06-0.43-17.8
Upgrade
Change in Accounts Payable
13.1413.9-4.7-3.342.81-1.25
Upgrade
Change in Unearned Revenue
-1.06-1.310.42-6.28-17.8729.24
Upgrade
Change in Income Taxes
-4.892.31-1.781.58-3.989.14
Upgrade
Change in Other Net Operating Assets
2.771.29-14.876.34-8.93-4.95
Upgrade
Operating Cash Flow
52.8797.0549.58137.8578.854.59
Upgrade
Operating Cash Flow Growth
53.87%95.75%-64.04%74.94%44.36%-
Upgrade
Capital Expenditures
-1.93-1.82-3.52-12.35-8.76-4.46
Upgrade
Cash Acquisitions
---10.41---404.88
Upgrade
Divestitures
-----22.06
Upgrade
Sale (Purchase) of Intangibles
----0.491.36
Upgrade
Investment in Securities
-121.51-136.0852.15182.4240.01615.67
Upgrade
Other Investing Activities
-11.56-5.77-49.91-6.44-1.221.9
Upgrade
Investing Cash Flow
-135-143.66-11.68163.6230.52231.65
Upgrade
Long-Term Debt Repaid
--0.03-76.9-261-164.95-231.76
Upgrade
Net Debt Issued (Repaid)
-0.03-0.03-76.9-261-164.95-231.76
Upgrade
Issuance of Common Stock
91.65102.7322.453.2333.763.02
Upgrade
Repurchase of Common Stock
-10.95-5.14-4.55-8.24-6.02-79.48
Upgrade
Other Financing Activities
-0.46-0.43-0.95-9.98-0.56-2.33
Upgrade
Financing Cash Flow
80.2197.14-59.95-275.99-137.76-310.55
Upgrade
Foreign Exchange Rate Adjustments
-0.11-1.17----
Upgrade
Net Cash Flow
-2.149.35-22.0525.48-28.44-24.31
Upgrade
Free Cash Flow
50.9495.2346.06125.570.0450.13
Upgrade
Free Cash Flow Growth
53.67%106.76%-63.30%79.19%39.72%-
Upgrade
Free Cash Flow Margin
28.07%56.98%35.07%63.95%29.00%30.65%
Upgrade
Free Cash Flow Per Share
2.735.212.597.444.062.98
Upgrade
Cash Interest Paid
0.30.260.291.433.034.46
Upgrade
Cash Income Tax Paid
19.4919.218.7711.643.722.13
Upgrade
Levered Free Cash Flow
63.35100.7946.03136.9337.03123.51
Upgrade
Unlevered Free Cash Flow
65.16102.246.2137.3332.6117.57
Upgrade
Change in Net Working Capital
1.11-11.1820.42-53.0685.65-40.29
Upgrade
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q